Statistics for enVVeno Medical (id:5860 NVNO)
Valuation metrics
Market cap
59.80M
Enterprise value
10.64M
Trailing P/E (ttm)
-1.79
Forward P/E
-2.87
PEG ratio
-2.87
Price/Sales (ttm)
Price/Book (mrq)
1.26
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.46
Overview
Shares outstanding
17.54M
Float
17.48M
Shares short
507.89K
% Held by insiders
0.00%
% Held by institutions
0.30%
Average volume (10 days)
139.99K
Average volume (90 days)
Price summary
52-Week low
3.01
52-Week high
6.97
52-Week change
-11.44%
Beta
1.22
50-Day moving average
3.65
200-Day moving average
4.88
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
November 30th, 2020
Ex-dividend date
Last split factor
2:1
Last split date
November 30th, 2020
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-37.28%
Return on equity
-58.76%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-23,201,000.00
Net income to common (ttm)
-21,239,000.00
Diluted EPS (ttm)
-1.29
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
48.38M
Total cash per share (mrq)
2.76
Total debt (mrq)
1.15M
Total Debt/Equity (mrq)
2.42
Current ratio (mrq)
2.20K%
Book value per share (mrq)
2.70
Cash flow
Cash flow statement
-16,706,000.00
Levered free cash flow (LFCF)
-9,838,125.00